Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 09 January 2025
      News
 
  08 January 2025 DIGITAL LEAP: Industry Proposes Phased Rollout of ePI for Patient Safety and Environmental...

By transitioning to ePI, patients, healthcare professionals (HCPs), and civil society will benefit from the most up-to-date,...

Read more →
 
 
 
  08 January 2025 With NIRO navigate innovation and research opportunities

2025 has arrived, bringing a host of opportunities for R&I! Find which one(s) could best help you pursue groundbreaking...

Read more →
 
 
 
      IHI RealiseD project: A new era for clinical trials in rare and ultra-rare diseases

Today marks the launch of IHI RealiseD project: A new era for clinical trials in rare and ultra-rare diseases! This European public-private partnership formed by nearly 40 partners, is on a mission to optimise and accelerate the development of treatments for rare and ultra-rare conditions.

Learn more here.

 
 
      Missed the EFPIA Conference? Watch the recordings!
 
 
 
IMAGINE a healthier, more competitive Europe - Part 1
 
 
IMAGINE a healthier, more competitive Europe - Part 2
 
 
 
 
      Events
 
 
28 JAN 2025
  EU Health Summit 2025: Reshaping health for a stronger Europe Brussels, Belgium

Join the EU Health Summit on 28 January to help shape a roadmap for a healthier Europe.

Learn more →
 
 
 
04 FEB 2025
  In conversation with... Beat-DKD and Hypo-Resolve Online event

People who have diabetes are also more likely to develop certain complications, such as hypoglycaemia and diabetic kidney...

Learn more →
 
 
      60,000 fewer clinical trial places for Europeans, despite global surge in research projects

Where innovation happens matters: clinical trials provide patients with the earliest access to new medicines. Our report shows that clinical trials are increasingly taking place in other regions of the world, meaning people living in Europe are missing out on the opportunity to access the latest breakthroughs.

Read more here

 
 
      What we are reading
EIC Tech Report 2024 18 December 2024  (European Innovation Council) Read more →
Calls for less bureaucracy, more cooperation to promote EU pharmaceutical competitiveness 11 December 2024  (Euractiv) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe